Significant funding support for HIV Vaccine Clinical Trial
HONG KONG SAR –
Media OutReach – 17 October 2022 –
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today that Hong Kong Science and Technology Parks Corporation (“
HKSTP”) has awarded maximum amount of HK$8 million matching funding to Immuno Cure under the Clinical Translational Catalyst program (“
CTC Program”) for conducting the Phase 1 Clinical Trial of ICVAX, a therapeutic vaccine against HIV/AIDS.
The overarching aim of the CTC Program offered by HKSTP Institute for Translational Research (“
ITR”) is to provide a platform to transform Hong Kong and Greater Bay Area to become the go-to destination for translational medicine in the region. Under this program, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patients.
The CTC Program funding of HK$8 million will be drawn down by Immuno Cure in the next 27 months in various tranches according to the progress of the clinical trial of ICVAX. Immuno Cure previously received the University-Industry Collaboration Programme and Cash Rebate Scheme funding of some HK$8.4 million from the Government’s Innovation and Technology Fund (“
ITF”) for the research and development of ICVAX since early 2018. As a collaborator, the AIDS Institute of The Hong Kong University has subsequently received a total amount of HK$ 47 million from Government’s Research Grants Council Theme-based Research Scheme for basic and translational research on “Potentiating Host Immunity for HIV-1 Functional Cure”.
ICVAX is a therapeutic HIV DNA vaccine developed using the patented PD-1-Enhanced DNA Vaccine platform, aiming to induce cross-reactive viral-specific T cells to achieve functional cure in HIV. This vaccine is developed by Immuno Cure in collaboration with HKU AIDS Institute. Immuno Cure has successfully obtained the approval of Investigational New Drug application of ICVAX by the National Medical Products Administration in the Mainland. Together with the approval granted by the ethics committee of The Third People’s Hospital of Shenzhen, Immuno Cure is initiating a First-in-Human Phase 1 clinical trial of ICVAX in the hospital.
The trial is designed as a randomized, double-blinded, placebo-controlled, dose-escalation study to evaluate the safety and immunogenicity of ICVAX in stable HIV/AIDS patients under antiretroviral therapy. Overall, the study will take approximately 18-24 months to complete. By the end of the study, an optimal vaccine dosage that is both safe and immunogenic in stable HIV patients will be identified for subsequent clinical trials in the future. Immuno Cure is currently working closely with all partners involved to propel the study forward.
In addition to ICVAX, Immuno Cure currently has another PD-1-Enhanced DNA vaccine for prevention of COVID-19, ICCOV, in preparation for advancement to Phase 2 clinical trial.
Dr JIN Xia, CEO of Immuno Cure said, “Initiation of this phase 1 clinical trial is supported by promising preclinical study results and safety evaluation that demonstrated the antiviral activity of this potential first-in-class therapeutic vaccine designed and developed specifically against HIV. Our novel PD-1-Enhanced DNA vaccine platform is ready for first-in-human trial and we are very pleased to be in the forefront of the field. We are honoured to receive this funding support from HKSTP and are optimistic that our long-term collaboration with HKU AIDS Institute will bear fruit.”
Professor CHEN Zhiwei, Director of AIDS Institute at the University of Hong Kong and the Principal Scientific Advisor of Immuno Cure said, “HIV has been a major public health challenge for more than four decades. Our vaccine platform has demonstrated safety and potent efficacy in non-human primates. I hope the HKSTP support and private funding from Immuno Cure together with research grant from the Government will help us to assess whether the excellent preclinical data could be translated into human and lay solid foundation for drug development towards functional cure of HIV patients.”
Dr Percy CHENG, Chairman of Immuno Cure concludes, “We are privileged to be partnering with HKU AIDS Institute and HKSTP ITR and grateful for this CTC Program funding in support of our translational process. We also treasure the funding support from ITF since 2018 during the early stage of the development of ICVAX. We would
also like to express our special thanks to our volunteers in advance for their selfless contributions, without whom we would not be able to kick off this exciting clinical trial.”
Hashtag: #ImmunoCureBiotech #医克生物 #HongKongSciencePark #香港科技園公司 #香港科技园公司
Immuno Cure BioTech
Immuno Cure BioTech is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of vaccines and immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-Enhanced DNA vaccine and Anti-Δ42-PD1 Blocking Antibody technology platforms.
To learn more about Immuno Cure BioTech, please visit https://www.immunocure.hk/en/
Hong Kong Science and Technology Parks Corporation
Comprising Science Park, InnoCentre and Industrial Estates, Hong Kong Science & Technology Parks Corporation (HKSTP) is a statutory body dedicated to building a vibrant innovation and technology ecosystem to connect stakeholders, nurture technology talents, facilitate collaboration, and catalyse innovations to deliver social and economic benefits to Hong Kong and the region.
Established in May 2001, HKSTP has been driving the development of Hong Kong into a regional hub for innovation and growth in several focused clusters including Electronics, Information Communications Technology, Green Technology, Biomedical Technology, Materials and Precision Engineering. HKSTP enables science and technology companies to nurture ideas, innovate and grow, supported by its R&D facilities, infrastructure, and market-led laboratories and technical centres with professional support services. HKSTP also offers value added services and comprehensive incubation programmes for technology start-ups to accelerate their growth.
Technology businesses benefit from the specialised services and infrastructure provided at Science Park for applied research and product development; enterprises can find creative design support at InnoCentre; while skill-intensive businesses are served by the three industrial estates at Tai Po, Tseung Kwan O and Yuen Long.
To learn more about Hong Kong Science and Technology Parks Corporation, please visit http://www.hkstp.org
AIDS Institute, HKUMed
The AIDS Institute of the University of Hong Kong was established in November 2007 to take HKU in a new strategic direction in fighting this global epidemic and help to make it a leader in the region in AIDS research, education and prevention. Scientists at the AIDS Institute are fully committed to conducting basic and applied research that facilitates the understanding of AIDS pathogenesis and the development of effective AIDS vaccines. Activities in the Institute include: basic research to examine the virological and immunological mechanisms underlying HIV pathogenesis; new concept, design, preparation and laboratory testing of vaccine candidates for HIV and other infectious diseases; and monitoring the evolution of HIV epidemic in Hong Kong and in the region.
To learn more about AIDS Institute of the University of Hong Kong, please visit https://www.med.hku.hk/aidsinst/
Services
Stakeholder mapping, analysis, engagement and communication needs to be detailed to avoid business losses or even worse, a crisis. How can you do this effectively to prevent failure? ...
Data-driven business decisions have never been as crucial, especially in this era. MGBF leverages off, technology, experience and market presence to aid businesses in making accurate decisions. ...
MGBF provides comprehensive strategic advice and results-focused solutions to solve clients' problems in business-government relations so they can focus on their core business. ...
A critical business challenge is meeting the right decision-makers and potential buyers through the best channel and platform. How will you improve your business competency? ...
Upcoming Events
In this episode of 'A Working Lunch with Nordin', MGBF's Nordin Abdullah and regional commentator Eddin Khoo will discuss the biggest threats and opportunities for businesses as we look to manage change in the South China Sea.
This MGBF Roundtable will feature thought leaders form Japan, Australia, Singapore and Malaysia dealing with the critical issues of manipulation of public listed companies and government and their financial impacts.
A series of networking sessions with various business associations and trade organisations exploring high-value opportunities for business leaders and entrepreneurs looking to build the relationships that matter.
This integrated event will include a forum, dedicated business matching, site visits, a gala dinner and a round of golf. Aptly themed, the focus will be on regional food security issues and trends in the context of the supply chain, agriculture technology and trade regulations and policies.
MGBF In The News
Planet QEOS and China Machinery Engineering Corporation (CMEC) are interested in investing RM10 billion to co-develop advanced Megawatt peak (MWp) agrovoltaic in Baram, to further boost Sarawak’s green energy initiative and food security. Sarawak Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg was briefed on Friday by both the […]
Last week SPM results came out, 373,974 aspirants who have been waiting patiently over the last few months would now know their fate. Some 10,109 have received all A’s, the golden standard of academic success and the ticket to those looking to study the “more advanced” subjects in university. Proudly, […]
The classic knee-jerk reaction is to say, fire the coach, change the leadership of associations, and reduce the funding till they start performing better. This kind of negative reinforcement may work for kindergarten children, but we are dealing with high-performance adults – individuals much further along in their psychological and […]
Since its earliest tea plantations in 1929, Cameron Highlands has grown to become a key player in the agricultural landscape of Malaysia, producing 40 per cent of all vegetables grown. Despite Malaysia shifting its economic focus away from agriculture, the industry remains imperative for food security and the livelihoods of […]
Although at first glance the travel industry and the agricultural sector appear to have nothing in common, they actually share more than meets the eye. The economic benefits of tourism to the agricultural sector can be multiplied several times over. “Tourism brings the end consumers closer to the source, which […]
The Malaysia Global Business Forum (MGBF) recently held a high-level roundtable themed ‘Designing the Future of the Digital Economy’, attended by industry leaders and business associations. The guest of honour was Yang Berhormat Syerleena Abdul Rashid, the Member of Parliament (MP) for Bukit Bendera in Penang. The MP’s Special Session […]
The Malaysia Global Business Forum (MGBF) will be hosting a roundtable on ‘Designing the Future of the Digital Economy’ on 23 February 2023. It is the culmination of the first three MGBF Exclusive Roundtable Series titled ‘The Evolving Threat Matrix in the Digital Economy’ held throughout 2022. According to the […]
The Founding Chairman of the Malaysia Global Business Forum (MGBF), Nordin Abdullah, today spoke on Bernama TV’s leading English talk show, The Brief, hosted by Jessy Chahal, on the topic of a stable political reality and what that means for the Malaysian economy. Nordin said, “The first thing that it […]
More than 1,100 years ago, Muhammad ibn Musa al-Khwarizmi was developing the mathematical formulas that we know today as algorithms which now have become so intertwined with the business fortunes of global media giants and the very fabric of geopolitics. A series of recent high level international reports have revealed […]
KSK Land has been recognised by the Malaysia Global Business Forum (MGBF) for its role in attracting high net-worth individuals to Malaysia post-pandemic. The first challenge in investor attraction is “selling” the country. In the context of Asia, Malaysia is competing with some very established investment destinations. The second […]
Malaysia, in particular Kuala Lumpur, continues to position itself as a regional centre to do business, educate a family and enjoy a global lifestyle. One company, KSK Land, has taken the lead in positioning itself and the city of Kuala Lumpur as a property investment destination for the global citizen […]
The upcoming budget represents an opportunity to build resilience in the critical sectors that will form the backbone of the country’s future-facing economic ambitions. This however needs to be achieved in the context of managing the community sectors most impacted by COVID-19 over the past two years. The Keluarga Malaysia (Malaysian Family) […]
Malaysia Global Business Forum (MGBF) has moved to support the creative economy as the overall economy moves into a recovery phase following the COVID19 pandemic. As a step in the direction of normalcy, the MGBF has agreed to host the art exhibition “I Know You’re Somewhere So Far” by one […]
Congratulations to Datuk Seri Ismail Sabri Yaakob for taking up the mantle of the ninth prime minister of Malaysia. There is nothing normal about the situation; it could not have been scripted but it has kept the spectrum of media, mainstream and social, gripped. The first order of business for […]
In a stirring speech to the nation, President Joseph R. Biden, Jr. stamped his brand of leadership on the presidency, in his first act as the 46th president of the United State of America, it signaled several shifts. Perhaps the weather was foreboding with snow falling before the ceremony that […]
KUALA LUMPUR, 6 July 2022 – As the global economy continues to deal with unprecedented levels of disruption caused by the pandemic and the conflict between Russia and Ukraine, the convergence of energy security and food security issues has become a front-of-mind issue faced by policy makers and consumers alike. […]
KUALA LUMPUR, 23 June 2022 — Malaysia Global Business Forum (MGBF) ties up with scoutAsia to ensure that businesses are equipped with deeper regional insights. The past two years has seen a massive shift in the way businesses are conducted with digitisation, digitalisation and automation continuously being adopted to improve […]
KUALA LUMPUR, 25 May 2022 – The Malaysia Global Business Forum (MGBF)’s exclusive roundtable on ‘Security Concerns in Critical Value Chains’ was held in a hybrid setting yesterday at the Eastin Hotel Kuala Lumpur. The guest of honour was Yang Berbahagia Tan Sri Dato’ Seri Rafidah Aziz, former minister of […]
We live in the age of crisis. At the heart of any crisis is the threat of rapid change. Change too deep or too wide that the current coping mechanisms for an individual, corporation or government are unable to remain resilient. An unwelcome paradigm shift, like the proverbial spider, that […]